Autolus Therapeutics plc (AUTL) NASDAQ
1.62
-0.13(-7.43%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.62
-0.13(-7.43%)
Currency In USD
| Market Cap | 529.62M |
| Enterprise Value | 777.07M |
| P/E Ratio | -1.49 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 4.66 |
| Price/Book Ratio | 3.96 |
| Enterprise/Revenue | 4.11 |
| Enterprise/EBITDA | -1.53 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.12 |
| Operating Margin | -2.86 |
| Return On Assets | -0.55 |
| Return On Equity | -1.29 |
| Revenue | 75.56M |
| Revenue/Share | 0.35 |
| Gross Profit | -21.03M |
| EBITDA | -271.6M |
| Net Income | -288.2M |
| Diluted EPS | -1.08 |
| Total Cash | 229.43M |
| Total Cash/Share | 0.86 |
| Total Debt | 79.96M |
| Total Debt/Equity | 0.73 |
| Current Ratio | 5.8 |
| Book Value Per Share | 0.41 |
| 52-Week Change | -21.74 |
| 52-Week High | 2.7 |
| 52-Week Low | 1.18 |
| Moving Average 50 Days | 1.54 |
| Moving Average 200 Days | 1.54 |
| Average Volume | 1.63M |
| Shares Outstanding | 266.14M |
| % Held by Institutions | 50.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |